Measuring the size of hypertrophic scars and keloids using 3D cameras after surgery
Official title: Quantification of Hypertrophic Scar Tissue or Keloid Using a 3D-Camera
Run by University of Zurich · NCT06806735 · Data updated 2026-11-12
This study is testing whether a 3D camera can help measure the size of scars and keloids in patients after surgery to see how they change over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich, Canton of Zurich) |
| Status | Recruiting |
| Started | January 10, 2025 |
| Main results expected | September 30, 2025 |
| Study ends | September 30, 2025 |
| Registry record updated | February 7, 2025 |
| Trial ID | NCT06806735 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have hypertrophic scars or keloids following surgery.
✕Probably not a fit
Patients without hypertrophic scars or keloids, or those unable to provide consent, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to measure the volumes of hypertrophic scars and keloids in patients who have undergone surgery, using a 3D camera at various time points: day 0, 3 months, 6 months, and 12 months post-surgery. The focus is on evaluating the effectiveness of the 3D camera as a tool for measuring and documenting scar volumes through volumetry. By capturing detailed three-dimensional images, the study seeks to provide a more accurate assessment of scar progression over time.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of hypertrophic scars and keloids, leading to better treatment strategies.
How similar studies have gone: While the use of 3D imaging in medical assessments is growing, this specific approach to measuring scar volumes is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients with hypertrophic scars or keloids, written consent to participate in the study, minimum age of 18 years. Exclusion Criteria: * Absence of written consent, unwillingness to contribute data, inability to understand the study protocol. * lack of hypertrophic scars or keloid
Where it's running
-
Universitätsspital Zürich
Zurich, Canton of Zurich, Switzerland Recruiting
Study contacts
- Study coordinator: Prof. Dr. med. Soyka
- Email: rhinologie@usz.ch
- Phone: +41 44 255 58 33
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brief topical cryotherapy before steroid injections for keloid and hypertrophic scars
This study will test whether applying a short burst of topical cryotherapy just before steroid injections lowers pain and makes injections easier for adults getting intralesional triamcinolone for keloid or hypertrophic scars.
-
Chitosan cream versus silicone gel and olive oil for preventing hypertrophic scars
We will test whether applying chitosan cream twice daily can prevent hypertrophic scars in adults whose surgical or traumatic wounds have healed by primary intention within 14 days.
-
Evaluating a scar gel for preventing hypertrophic scars
This study tests a new scar gel to see if it can help prevent raised scars in people with recent scars compared to a standard product.
-
Treatment for various skin conditions using AVAVA technology
This study is testing a new device called AVAVA to see if it can help improve skin problems like acne, scars, and wrinkles.
-
Using a hybrid laser to treat acne scars in people with darker skin
This study is testing a new type of laser treatment for acne scars to see if it works well and is safe for people with darker skin.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.